MelvinBergerMDPhD

PubMed

• 4 citations
  Hereditary angioedema C1-esterase inhibitor replacement therapy and coexisting autoimmune disorders: findings from a claims database
  Henriette Farkas, Donald Levy, Dylan Supina, Melvin Berger, Subhransu Prusty, Moshe Fridman> ;Allergy, Asthma, and Clinical Immunology. 2020 May 27
• Gender, Parenthood, and the Medical Record.
  M. Berger> ;The Journal of Allergy and Clinical Immunology. in Practice. 2020 Feb 1
• 3 citations
  Antibodies to vaccine antigens in pooled polyclonal human IgG products
  Melvin Berger> ;Transfusion. 2018 Dec 7
• 18 citations
  Alpha-1-antitrypsin in cell and organ transplantation.
  Melvin Berger, Mingyao Liu, Marc E. Uknis, Maria Koulmanda> ;American Journal of Transplantation. 2018 Apr 24
• 19 citations
  Individualized immunoglobulin therapy in chronic immune-mediated peripheral neuropathies.
  Jeffrey A. Allen, Melvin Berger, Luis Querol, Krista Kuitwaard, Robert D M Hadden> ;Journal of the Peripheral Nervous System. 2018 Mar 23
• 8 citations
  IgPro20, the Polyneuropathy and Treatment with Hizentra® study (PATH), and the treatment of chronic inflammatory demyelinating polyradiculoneuropathy with subcutaneous...
  Melvin Berger, Thomas Harbo, David R. Cornblath, Orell Mielke> ;Immunotherapy. 2018 May 16
• Correction to: Assessment of Local Adverse Reactions to Subcutaneous Immunoglobulin (SCIG) in Clinical Trials.
  Mark Ballow, Richard L. Wasserman, Stephen Jolles, Helen Chapel, Melvin Berger, Siraj A. Misbah> ;Journal of Clinical Immunology. 2018 Apr 27
• 32 citations
  Primary immune deficiency diseases as unrecognized causes of chronic respiratory disease.
  Melvin Berger, Bob Geng, D. William Cameron, Ladonna M. Murphy, Edward S. Schulman> ;Respiratory Medicine. 2017 Nov 1
• 38 citations
  Immunoglobulin therapy in hematologic neoplasms and after hematopoietic cell transplantation.
  Masumi Ueda, Melvin Berger, Robert Peter Gale, Hillard M. Lazarus> ;Blood Reviews. 2017 Sep 19
• 26 citations
  Role of anti-receptor autoantibodies in pathophysiology of scleroderma.
  Melvin Berger, Virginia D. Steen> ;Autoimmunity Reviews. 2017 Oct 1
• 3 citations
  Assessment of local adverse reactions to subcutaneous immunoglobulin (SCIG) in clinical trials
  Mark Ballow, Richard L. Wasserman, Stephen Jolles, Helen Chapel, Melvin Berger, Siraj A. Misbah> ;Journal of Clinical Immunology. 2017 Jul 10
• 31 citations
  Potential Roles for C1 Inhibitor in Transplantation.
  Melvin Berger, William M. Baldwin, Stanley C. Jordan> ;Transplantation. 2016 Jul 1
• Efficient Utilization of IgG for Antibody Replacement Therapy.
  Melvin Berger> ;The Journal of Allergy and Clinical Immunology. in Practice. 2015 Nov 1
• 17 citations
  In vitro evaluation of cytomegalovirus-specific hyperimmune globulins vs. standard intravenous immunoglobulins.
  Sylvia Miescher, T. M. Huber, M. Kühne, P. Lieby, David R. Snydman, Judith Vensak, Melvin Berger> ;Vox Sanguinis. 2015 Jul 1
• 43 citations
  Commercially Available Immunoglobulins Contain Virus Neutralizing Antibodies Against All Major Genotypes of Polyomavirus BK
  P. Randhawa, Diana V. Pastrana, Gang Zeng, Yuchen Huang, Ron Shapiro, Puneet Sood, Chethan Puttarajappa, Melvin Berger, Sundaram Hariharan, Christopher B. Buck> ;American Journal of Transplantation. 2015 Apr 1
• 28 citations
  Optimizing IgG Therapy in Chronic Autoimmune Neuropathies: A Hypothesis Driven Approach
  Melvin Berger, Jeffrey A. Allen> ;Muscle & Nerve. 2015 Mar 1
• 104 citations
  Current treatment options with immunoglobulin G for the individualization of care in patients with primary immunodeficiency disease.
  Stephen Jolles, Jordan S. Orange, Ann Gardulf, Mark R. Stein, Ron Shapiro, Michael Borte, Melvin Berger> ;Clinical and Experimental Immunology. 2015 Feb 1
• Optimizing immunoglobulin G therapy in chronic autoimmune neuropathies.
  M. Berger> ;Clinical and Experimental Immunology. 2014 Dec 1
• 2 citations
  Clinical Experience With an L-Proline–Stabilized 10 % Intravenous Immunoglobulin (Privigen®): Real-Life Effectiveness and Tolerability
  Morna J. Dorsey, Viet Ho, Mohsen I. Mabudian, Pere Soler-Palacín, Nerea Domínguez-Pinilla, Radha Gandhi Rishi, Rahul Rishi, Duane Wong, Mikhail Rojavin, Alphonse Hubsc...> ;Journal of Clinical Immunology. 2014 Jul 1
• 17 citations
  Subcutaneous IgG in neurologic diseases.
  Melvin Berger> ;Immunotherapy. 2014 Jan 1
• 46 citations
  Immediate hypersensitivity reactions following monovalent 2009 pandemic influenza A (H1N1) vaccines: reports to VAERS.
  Neal A. Halsey, Mari Griffioen, Stephen C. Dreskin, Cornelia L. Dekker, Robert Wood, Devindra Sharma, James F. Jones, Philip S. LaRussa, Jenny Garner, Melvin Berger, T...> ;Vaccine. 2013 Dec 9
• 38 citations
  Rapid and reversible responses to IVIG in autoimmune neuromuscular diseases suggest mechanisms of action involving competition with functionally important autoantibodies
  Melvin Berger, Daniel E. McCallus, Cindy S.-Y. Lin> ;Journal of the Peripheral Nervous System. 2013 Dec 1
• 3 citations
  Intramuscular versus intravenous immunoglobulin replacement therapy and measurement of immunoglobulin levels during immunoglobulin replacement therapy.
  Phillip Lieberman, Melvin Berger> ;The Journal of Allergy and Clinical Immunology. in Practice. 2013 Nov 1
• 50 citations
  Adverse effects of IgG therapy.
  Melvin Berger> ;The Journal of Allergy and Clinical Immunology. in Practice. 2013 Nov 1
• 8 citations
  Comprehensive assessment of serious adverse events following immunization by health care providers.
  S. Elizabeth Williams, Kathryn M. Edwards, Roger Baxter, Philip LaRussa, Neal A. Halsey, Cornelia L. Dekker, Claudia Vellozzi, Colin D. Marchant, Peter D. Donofrio, Ty...> ;The Journal of Pediatrics. 2013 Jun 1
• Join now to see all

Journal Articles

• Review and assessment of the donor safety among plasma donors  
  Mitali Purohit 1, Mel Berger, Rachpal Malhotra , Toby Simon, Transfusion (doi: 10.1111/trf.17369), 4/19/2023